The characteristic of exhaled breath condensate in patients with diabetes mellitus

T. Z. Seisembekov, V. N. Zelenskaya, E. V. Bjul, S. B. Dzhautikova (Astana, Kazakhstan)

Source: Annual Congress 2003 - Third ERS – free paper symposium on interdisciplinary basic and clinical surfactant research
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Z. Seisembekov, V. N. Zelenskaya, E. V. Bjul, S. B. Dzhautikova (Astana, Kazakhstan). The characteristic of exhaled breath condensate in patients with diabetes mellitus. Eur Respir J 2003; 22: Suppl. 45, 1430

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled breath analysis in patients with diabetes mellitus using an electronic nose
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Content of total lipids in the exhaled breath condensate in type 1 diabetic mellitus patients with different level HbA1c
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Cytokines in exhaled breath condensate of patients with asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

TNF-α in exhaled breath condensate and in serum of scleroderma patients
Source: Eur Respir J 2003; 22: Suppl. 45, 448s
Year: 2003

Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 283s
Year: 2006

Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



Eotaxin in exhaled breath condensate of stable and unstable asthma patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

8-isoprostane in breath condensate in patients with exacerbation of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001

Structures of an exhaled breath condensate in lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 525s
Year: 2005

pH in exhaled breath condensate of patients with stable and unstable asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 508s
Year: 2004

Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 671s
Year: 2006

Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 227s
Year: 2005

Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Metabonomics applied to exhaled breath condensate in childhood asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 123s
Year: 2006

Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 438s
Year: 2003

Exhaled breath condensate pH for the identification of asymptomatic children at risk of asthma
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010

Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010